Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2001
11/28/2001CN1324361A Aluminoxane synthesis employing reduced amount of trialkylaluminium compound
11/28/2001CN1324258A Aglyco products and method of use
11/28/2001CN1324257A Vaporizing device for administering sterile medication
11/28/2001CN1324251A Method of stimulating prosaposin receptor activity
11/28/2001CN1324250A Method for treating or preventing viral infections and associated diseases
11/28/2001CN1324246A Method for enhancing wound healing
11/28/2001CN1324245A Activation and protection of T-cells (CD4+ and CD8+) using and H2 receptor agonist and other T-cell activating agents
11/28/2001CN1324244A Methods for treating sepsis
11/28/2001CN1324243A Method for treating inflammatory inflammatory diseases using heat shock proteins
11/28/2001CN1324242A Novel NEUROPILIN/growth factor binding and use thereof
11/28/2001CN1324241A Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of LH-RH analogues
11/28/2001CN1324237A Method for improving pharmacokinetics of tipranavir
11/28/2001CN1324212A Method for treating or preventing viral infections and associated diseases
11/28/2001CN1323901A New polypeptide-DNA topoisomerase I-12 and polynucleotides for coding same
11/28/2001CN1323899A New polypeptide-human phosphatidase 16 and polynucleotides for coding same
11/28/2001CN1323897A New polypeptide-human ubiquitin C terminal hydrolase 9 and polynucleotides for coding same
11/28/2001CN1323896A New polypeptide-human RNA uncoiling enzyme 12 and polynucleotides for coding same
11/28/2001CN1323895A New polypeptide-N-acetylgalactosamine transferase-28 and polynucleotides for coding same
11/28/2001CN1323892A New polypeptide-human aldehyde/ketone reductase 9.2 and polynucleotides for coding same
11/28/2001CN1323890A New polypeptide-human aldehyde/ketone reductase 9.9 and polynucleotides for coding same
11/28/2001CN1323889A New polypeptide-human sailer transposase 11 and polynucleotides for coding same
11/28/2001CN1323836A New polypeptide-human zinc finger protein 11 and polynucleotides for coding same
11/28/2001CN1323834A New polypeptide-human ATp dependent uncoiling enzyme protein 10 and polynucleotides for coding same
11/28/2001CN1323828A New polypeptide-human zinc finger protein 12 and polynucleotides for coding same
11/28/2001CN1323827A New polypeptide-human transcriptional activation protein subunit 14 and polynucleotides for coding same
11/28/2001CN1323826A New polypeptide-human S4 ribosomal protein 10 and polynucleotides for coding same
11/28/2001CN1323825A New polypeptide-human clathrin light chain 9 and polynucleotides for coding same
11/28/2001CN1323824A New polypeptide-human uteroglobin 9 and polynucleotides for coding same
11/28/2001CN1323823A New polypeptide-human beta-microtubulin folding accessory factor C-9 and polynucleotides for coding same
11/28/2001CN1323821A New polypeptide-human zinc finger protein 38 and polynucleotides for coding same
11/28/2001CN1323818A New polypeptide-human tumor suppressor factor 14 and polynucleotides for coding same
11/28/2001CN1323817A New polypeptide-zinc finger protein SCAN subfamily protein 57 and polynucleotides for coding same
11/28/2001CN1323813A New polypeptide-neural syndesis ion channel related protein 11 and polynucleotides for coding same
11/28/2001CN1323809A New polypeptide-human uteroglobin 12 and polynucleotide for coding same
11/28/2001CN1323806A New polypeptide-human neural cell adhesion protein 31 and polynucleotides for coding same
11/28/2001CN1323804A New polypeptide-human ribosome SII protein 12 and polynucleotides for coding same
11/28/2001CN1323803A New human protein with the function of inhibiting cancer cell growth and its coding sequence
11/28/2001CN1323802A New human protein with the function of inhibiting cancer cell growth and its coding sequence
11/28/2001CN1075501C Camptothecin derivatives, prepn. method, intermediate and uses
11/28/2001CN1075387C Antitumor agent potentiator comprising IL-6 antagonist
11/27/2001US6324479 Methods of determining protein activity levels using gene expression profiles
11/27/2001US6323335 Nucleotide sequences coding cell proliferation and differentiation polypeptide; for use in controlling cell proliferation and differentiation; for treating cancer
11/27/2001US6323334 Nucleic acid molecules encoding a 103 gene product and uses therefor
11/27/2001US6323333 Mouse EDG1
11/27/2001US6323331 Beclin-related nucleic acid molecules, and uses thereof
11/27/2001US6323330 Protein C16 and C16N or genes encoding the same
11/27/2001US6323329 Nucleic acid sequences of genes encoding high mobility group proteins
11/27/2001US6323326 Method of solubilizing, purifying, and refolding protein
11/27/2001US6323324 Test kits for detecting the presence of C-terminal hGPIIb fragments
11/27/2001US6323321 Monoclonal antibody which binds to an antigen on the megakaryocytic cell for use as diagnostic tool
11/27/2001US6323320 Acellular red blood cell substitute
11/27/2001US6323319 Method of making hydrolyzed collagen type II
11/27/2001US6323318 Human protein kinases hYAK3-2
11/27/2001US6323317 Therapeutic and diagnostics proteins comprising a SOCS box
11/27/2001US6323313 Genetically engineered binding protein for use in diagnosis, detection and treatment of vascular system thrombosis
11/27/2001US6323312 Cyclic CRF antagonist peptides
11/27/2001US6323311 Synthesis of insulin derivatives
11/27/2001US6323234 Methods to treat gastrointestinal lesions and to reduce drug-induced gastrointestinal or renal toxicity
11/27/2001US6323232 Combination therapy for osteoporosis
11/27/2001US6323185 Anti-viral guanosine-rich oligonucleotides and method of treating HIV
11/27/2001US6323184 Arteriovenous and venous graft treatments: methods and compositions
11/27/2001US6323181 Antitumor agents
11/27/2001US6323180 Protease inhibitors; inhibit replication of hepatitis c virus
11/27/2001US6323179 Chicken GNRH analogs and uses thereof in regulation of fertility and pregnancy
11/27/2001US6323178 Beta-lipotropin methods
11/27/2001US6323176 Cyclic peptide antifungal agents
11/27/2001US6323175 Composition comprising physiologically compatible liposome, hemoglobin encapsulated in liposome, and nitroxide encapsulated in liposome
11/27/2001US6323029 Therapeutic, diagnostic, and research applications for the modulation of glycogen synthase kinase 3 beta expression
11/27/2001US6323028 Isolated peptides which comply with HLA-CW16 molecules and uses
11/27/2001US6323027 Common gamma chain monoclonal antibody blocking agents
11/27/2001US6323024 Plasmids for the expression of heterologus genes; for use in treatment and prevention of viral diseases
11/27/2001US6323020 Neutralization-sensitive epitopes of Cryptosporidium parvum
11/27/2001US6323019 Design of novel highly efficient HIV based packaging systems for gene therapy
11/27/2001US6323016 Nucleotide sequences coding tyrosine kinase; for diagnosis and treatment of inflammation, cancer, arteriosclerosis, and psoriasis
11/27/2001US6323006 Recombinant human beta-CIS interferon
11/27/2001US6323000 To identify compounds that interact with it
11/27/2001US6322999 Cloned genes coding for human receptors, and cell lines expressing genes, in order to generate a proper screen for human therapeutic compounds
11/27/2001US6322996 Reacting a physiologically active protein with an amino group donor or alkylamine-containing polysaccharide in presence of transglutaminase, thereby modifying protein by forming an amido linkage between carboxyamide group of glutamine residue
11/27/2001US6322990 Methods of identifying agents that block the interaction of a BAP protein with a signaling partner
11/27/2001US6322982 Modulation of drug resistance via ubiquitin carboxy-terminal hydrolase
11/27/2001US6322978 Repeat polymorphism in the frataxin gene and uses therefore
11/27/2001US6322976 Compositions and methods of disease diagnosis and therapy
11/27/2001US6322972 Detecting suppressors of ligand binding; transform cells, propagate cells, expose to modulator, compare expression of reporter genes in presence and absence of compound, decrease in expression indicates modulators
11/27/2001US6322965 Chimera antigen peptide
11/27/2001US6322964 Synthetic HIV-2 gag and env oligopeptides reactive with HIV-2 specific antibodies
11/27/2001US6322826 High protein
11/27/2001US6322805 Amphiphilic block polymer having units of polyethers and polylactones
11/27/2001US6322804 Implantable biocompatible immunoisolatory vehicle for the delivery of selected therapeutic products
11/27/2001US6322797 Biodegradable terephthalate polyester-poly (phosphate) polymers, compositions, articles, and methods for making and using the same
11/27/2001US6322795 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses
11/27/2001US6322791 Haemopoietic growth factor antagonists and uses therefor
11/27/2001US6322790 Treatment of primary and metastatic noeplastic diseases and infectious diseases; administering antigen presenting cells sensitized with complexes of hsps noncovalently bound to an antigenic molecule
11/27/2001US6322786 Growing saos-2 cells, removing culture medium with serum, washing, incubating, collecting culture medium without serum, filtering, obtaining desired retentate
11/27/2001US6322784 Glucocorticoid, a compound which stimulates camp production and compound which upregulates peroxisome proliferator activated receptor .gamma. expression
11/27/2001US6322779 Purified, unglycosylated endotoxin and pyrogen-free, high specific biological activity; two monomer structure
11/27/2001CA2199941C Synthetic antibiotics
11/27/2001CA2145866C Human calcitonin receptor
11/27/2001CA2083286C Recombinant fibrinogenases, preparation and use thereof
11/27/2001CA2025294C Bile acid derivatives, processes for their preparation, and use as pharmaceuticals
11/27/2001CA2021912C Erythropoietin (epo) peptides and antibodies directed against these